IncubatorAgoranov is a public science and technology incubator located in Paris, France, specializing in supporting innovative startups in Industry & Greentech, Digital, and Health sectors.

Nexbiome Therapeutics is a biotechnology company based in France, specializing in the incubation of microbiome-related biotech projects. It focuses on translating academic research into viable drugs and products for human use.
Online destinations
Public destinations are grouped by their documented relationship to the organization. A listed link does not by itself prove ownership or control.
Destinations the organization presents as part of its public presence.
Nexbiome Therapeutics is a biotech studio founded in 2021, based in Clermont-Ferrand, France. The organization focuses on translating academic concepts into tangible drugs. It identifies innovative concepts through exclusive license agreements or equity participations in existing biotechs and designs, funds, and implements strategic roadmaps for drug development.
Nexbiome Therapeutics invests in projects that address unmet medical needs in high-impact areas. The organization manages drug development projects across non-clinical, preclinical, and clinical stages, adhering to pharmaceutical standards. Its investment strategy includes financing through equity and financial partners.
Superscout Pro

Superscout documents Nexbiome Therapeutics independently from canonical records and linked sources. Missing facts stay missing.
Last reviewed .
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Stage and region classifications are shown as recorded. Broad labels such as “Global” and category-like stage labels may still need normalization.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.